Adocia

PAR:ADOC · FR0011184241

BiotechnologySmall

360° View

Value77

Price/Sales85

Price/Earnings69

Price/Book31

Dividend Yield1

Growth88

Revenue Growth93

Profit Growth63

Capital Growth46

TSR 52w65

Safety12

Leverage12

Liquidity38

Refinancing32

Combined56

Sentiment57

Analyst Opinions69

Pro Holdings39

Opinion Changes50

Market Pulse49

Profile

CountryFrance

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeENXTPA

Founded2005

Employees77

Websiteadocia.com

ISINFR0011184241

Last UpdateApr 2, 2026

Index & Theme

DiabetesEndocrinologyObesityAlternative MedicineBiotechnologyTherapeutics

Description

Adocia SA (Adocia), a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Business Segments The company concentrate…

Analysis

Adocia's 360° View rank of 63 places it above its peer average — better than 63% of its true peers.

It's a growth standout (88) and looks cheap versus peers (77). On safety it is highly leveraged (12), and the market shows favorable sentiment (57). Taken together, its Combined rank of 56 reads as above its peer average.

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Adocia with its peers

Tiziana Life Sciences

NAQ:TLSA

CountryUK

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Inventiva

PAR:IVA

CountryFrance

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

BB Biotech

SWX:BION

CountrySwitzerland

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Galapagos

AEX:GLPG

CountryBelgium

IndustryBiotechnology

SizeMedium

Full Stock Analysis →

BioNTech

NSQ:BNTX

CountryGermany

IndustryBiotechnology

SizeLarge

Full Stock Analysis →

Kamada

NSQ:KMDA

CountryIsrael

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →